Long noncoding RNA KB-1980E6.3 promotes breast cancer progression through the PI3K/AKT signalling pathway

被引:7
|
作者
He, Lin [1 ]
Tang, Lingfeng [1 ]
Wang, Rui [2 ]
Liu, Li [1 ]
Zhu, Pengpeng [2 ]
Jiang, Kunwei [1 ]
Tu, Gang [1 ]
机构
[1] Chongqing Med Univ, Affiliated Hosp 1, Dept Endocrine & Breast Surg, 1 You Yi Rd, Chongqing 400016, Peoples R China
[2] Chongqing Med Univ, Key Lab Lab Med Diagnost, Chinese Minist Educ, Chongqing 400016, Peoples R China
基金
中国国家自然科学基金;
关键词
LncRNA KB-1980E6.3; Breast cancer; PI3K/AKT pathway; Proliferation; Invasion;
D O I
10.1016/j.prp.2022.153891
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
This research aims to investigate the effect of lncRNA KB-1980E6.3 on the biological behaviour of breast cancer cells under normoxic conditions and the underlying molecular mechanism. The expression of KB-1980E6.3 in breast cancer tissues and cells was detected by RT-qPCR. The proliferation, migration and invasion of cells were evaluated by CCK-8, colony formation, scratch and Transwell assays; KB-1980E6.3-related xenograft models were established for in vivo studies. The protein expression of PI3K, p-PI3K, AKT and p-AKT was validated by western blotting analysis. The levels of KB-1980E6.3 are significantly upregulated in breast cancer tissues and cells and are related to the poor prognosis. Functional research both in vivo and in vitro revealed that the downregulation of KB-1980E6.3 expression significantly decreased cell proliferation, invasion and migration, while ectopic KB-1980E6.3 expression obviously promoted these biological phenotypes. In terms of the mechanism, KB-1980E6.3 is involved in the activation of the PI3K/AKT signalling pathway. Knockdown of KB-1980E6.3 reduced the expression of the p-PI3K and p-AKT proteins, whereas KB-1980E6.3 overexpression showed the opposite result. The agonist 740Y-P and inhibitor LY294002 reversed the effect of KB-1980E6.3 knockdown and overexpression on the PI3K/AKT pathway in BC cells. KB-1980E6.3 promotes the proliferation, invasion and migration of breast cancer cells by activating PI3K/AKT signalling, which can be used as a potential target for breast cancer therapy.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Tollip promotes hepatocellular carcinoma progression via PI3K/AKT pathway
    Huang, Lu
    Yang, Qiong
    Chen, Huihong
    Wang, Zhenggeng
    Liu, Qi
    Ai, Shuhua
    OPEN MEDICINE, 2022, 17 (01): : 626 - 637
  • [42] SLC7A11 promotes the progression of gastric cancer and regulates ferroptosis through PI3K/AKT pathway
    Jiang, Yun
    Cui, Jingyi
    Cui, Ming
    Jing, Rongrong
    PATHOLOGY RESEARCH AND PRACTICE, 2023, 248
  • [43] miR-19b serves as a prognostic biomarker of breast cancer and promotes tumor progression through PI3K/AKT signaling pathway
    Li, Chuansheng
    Zhang, Jingwei
    Ma, Zhongliang
    Zhang, Fan
    Yu, Wenlong
    ONCOTARGETS AND THERAPY, 2018, 11 : 4087 - 4095
  • [44] USP7 promotes hepatoblastoma progression through activation of PI3K/AKT signaling pathway
    Ye, Mujie
    He, Jiajun
    Zhang, Jingjing
    Liu, Baihui
    Liu, Xiangqi
    Xie, Lulu
    Wei, Meng
    Dong, Rui
    Li, Kai
    Ma, Duan
    Dong, Kuiran
    CANCER BIOMARKERS, 2021, 31 (02) : 107 - 117
  • [45] TRAM2 promotes the malignant progression of glioma through PI3K/AKT/mTOR pathway
    Gao, Xiang
    Jiang, Wenqu
    Ke, Zunliang
    Huang, Qiwei
    Chen, Liang
    Zhang, Guobin
    Li, Chao
    Yu, Xiaojun
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2022, 586 : 34 - 41
  • [46] ILK promotes cell proliferation in breast cancer cells by activating the PI3K/Akt pathway
    Qu, Yikun
    Hao, Chunfang
    Xu, Jian
    Cheng, Zhuoxin
    Wang, Weiqun
    Liu, Hong
    MOLECULAR MEDICINE REPORTS, 2017, 16 (04) : 5036 - 5042
  • [47] Breast Cancer Invasion and Metastasis by mPRα Through the PI3K/Akt Signaling Pathway
    Wu, Xiaojuan
    Sun, Limin
    Wang, Xiao
    Su, Peng
    Li, Zhishuang
    Zhang, Chunyan
    Wang, Yan
    Gao, Peng
    Ma, Rong
    PATHOLOGY & ONCOLOGY RESEARCH, 2016, 22 (03) : 471 - 476
  • [48] TRMT6 promotes hepatocellular carcinoma progression through the PI3K/AKT signaling pathway
    Ye, Yanqing
    Liu, Maosheng
    Wu, Fengfei
    Ou, Shiyu
    Wang, Weidong
    Fei, Jieying
    Xie, Fang
    Bai, Lan
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2023, 28 (01)
  • [49] TRMT6 promotes hepatocellular carcinoma progression through the PI3K/AKT signaling pathway
    Yanqing Ye
    Maosheng Liu
    Fengfei Wu
    Shiyu Ou
    Weidong Wang
    Jieying Fei
    Fang Xie
    Lan Bai
    European Journal of Medical Research, 28
  • [50] COPS8 promotes hepatocellular carcinoma progression through the PI3K/AKT/mTOR pathway
    Yan, Xiaodong
    Li, Zhongmin
    Tian, Qing
    Zhang, Yamin
    ASIAN JOURNAL OF SURGERY, 2024, 47 (06) : 2947 - 2949